EUVIMEDEUVIMED entdecken
Crossref

Knowing The Nano: A look at current international laws that provide guidance on assessing the toxicity of nanomaterials for Crispr-based delivery of Human Genome Editing

Shanthi Van Zeebroeck

Global Bioethics Enquiry Journal · 2022

DOI: 10.38020/gbe.10.2.2022.96-100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Global Bioethics Enquiry Journal, 2022. Verfasst von Shanthi Van Zeebroeck.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Crispr, short for Clustered Regularly Interspaced Short Palindromic Repeats-associated protein 9, is a revolutionary gene editing technology that has proven to be the solution for eradicating fatal diseases by altering the human genome.As used in the genome of human, it is referred to as human genome editing, and involves alterations such as cutting out a defective gene mutation and replacing it with a corrected one, using Crispr.Although off targets, side effects and difficulties using a physical-viral based drug delivery method have been reported, there has also been a monumental development in terms of eradicating fatal diseases, using Crispr, such as Sickle Cell Disease [1], Leukemia [2] and HIV [3].Human genome editing using Crispr has also faced many challenges such as off-targets (not reaching target genes or reaching targeted and untargeted genes), and mosaicism (the presence of more than one genotype caused by edits [4].Arguably, however, the most challenging issue for Crispr is in its physical-viral delivery method, i.e., how to safely and efficiently deliver the components that are needed to use Crispr, which consists of a DNA cutting enzyme called Cas/9, and a short RNA that guides the enzyme to a target gene for edits.In Part 1 of this paper, an exploration of how researchers have turned to the use of non-viral delivery method using nanomaterials to combat this challenge will be explored.In Part 2 of this paper, a look at international laws on nanotoxicity that regulate the use of nanomaterials for human use will be explored.

Zitieren

APA

Zeebroeck, S. V. (2022). Knowing The Nano: A look at current international laws that provide guidance on assessing the toxicity of nanomaterials for Crispr-based delivery of Human Genome Editing. Global Bioethics Enquiry Journal. https://doi.org/10.38020/gbe.10.2.2022.96-100

Vancouver

Zeebroeck SV. Knowing The Nano: A look at current international laws that provide guidance on assessing the toxicity of nanomaterials for Crispr-based delivery of Human Genome Editing. Global Bioethics Enquiry Journal. 2022. doi:10.38020/gbe.10.2.2022.96-100

BibTeX
@article{Zeebroeck2022,
  author = {Zeebroeck, Shanthi Van},
  title = {Knowing The Nano: A look at current international laws that provide guidance on assessing the toxicity of nanomaterials for Crispr-based delivery of Human Genome Editing},
  journal = {Global Bioethics Enquiry Journal},
  year = {2022},
  doi = {10.38020/gbe.10.2.2022.96-100}
}
Kostenlos starten →